Lifeward Ltd. (NASDAQ:LFWD) Short Interest Update

Lifeward Ltd. (NASDAQ:LFWD) was the target of a significant decline in short interest in March. As of March 31st, there was short interest totaling 157,182 shares, a decline of 24.5% from the March 15th total of 208,221 shares. Based on an average trading volume of 13,323 shares, the short-interest ratio is currently 11.8 days. Approximately 10.4% of the company’s stock are short sold.

Lifeward Stock Down 1.4%

Shares of NASDAQ LFWD traded down $0.09 during midday trading on Wednesday, hitting $6.54. The stock had a trading volume of 3,151 shares, compared to its average volume of 23,331. The business’s 50 day moving average is $6.45 and its 200-day moving average is $7.32. The company has a market cap of $10.00 million, a P/E ratio of -0.35 and a beta of 0.16. Lifeward has a 52 week low of $4.14 and a 52 week high of $18.60.

Lifeward (NASDAQ:LFWD) last issued its earnings results on Thursday, March 19th. The company reported ($3.60) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by ($3.53). The firm had revenue of $5.08 million during the quarter, compared to the consensus estimate of $7.87 million. Lifeward had a negative return on equity of 145.55% and a negative net margin of 90.38%. As a group, analysts expect that Lifeward will post -1.78 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on LFWD. Weiss Ratings reiterated a “sell (e+)” rating on shares of Lifeward in a research note on Thursday, January 22nd. HC Wainwright upped their target price on shares of Lifeward to $10.00 and gave the stock a “buy” rating in a research note on Thursday, March 19th. One equities research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $10.00.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the stock. Virtu Financial LLC raised its holdings in shares of Lifeward by 158.0% during the fourth quarter. Virtu Financial LLC now owns 60,474 shares of the company’s stock valued at $35,000 after purchasing an additional 37,037 shares during the last quarter. Jane Street Group LLC raised its holdings in shares of Lifeward by 77.3% during the fourth quarter. Jane Street Group LLC now owns 68,631 shares of the company’s stock valued at $40,000 after purchasing an additional 29,927 shares during the last quarter. HRT Financial LP raised its holdings in shares of Lifeward by 149.7% during the fourth quarter. HRT Financial LP now owns 49,081 shares of the company’s stock valued at $28,000 after purchasing an additional 29,423 shares during the last quarter. Finally, Citadel Advisors LLC raised its holdings in shares of Lifeward by 1,271.8% during the third quarter. Citadel Advisors LLC now owns 214,006 shares of the company’s stock valued at $152,000 after purchasing an additional 198,406 shares during the last quarter. 26.76% of the stock is owned by hedge funds and other institutional investors.

About Lifeward

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.